Science ❯ Biotechnology
Gene Editing Gene Therapy De-extinction CRISPR Technology mRNA Technology Gene Expression Genome Editing Cloning DNA Analysis Embryology
The move reflects confidence that recurring cancer‑recurrence testing can sustain revenue growth following Natera's stronger quarter, higher test volumes, raised guidance,